COMMUNIQUÉS West-GlobeNewswire

Hernia Surgeon Discusses Surgery Costs in Los Angeles
18/12/2018
Dr. David Albin of the Southern California Hernia Center explains the inconsistencies inherent to medical costs in America and offers more transparent pricing for hernia surgery at his eight practice locations. LOS [...]
ProQR annonce la publication dans Nature Medicine des données du QR-110 pour l’amaurose congénitale de Leber 10
18/12/2018
LEIDEN, Pays-Bas et CAMBRIDGE, Massachusetts, 18 déc. 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq : PRQR), société qui s’efforce de changer les vies grâce à la création de médicaments à ARN transformateurs [...]
Communique from EGM in Oncology Venture A/S
18/12/2018
Company Announcement Communique from EGM in Oncology Venture A/S Hoersholm, Denmark, December 18, 2018 – today, an extraordinary general meeting in Oncology Venture A/S was held. A summary of the resolutions adopted [...]
Wildflower to Capitalize on Hemp Legalization
18/12/2018
VANCOUVER, British Columbia, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) is pleased with the passing of the 2018 Farm Bill, which includes the Hemp Farming Act of [...]
NanoVibronix Signs with Exclusive Distributor in Switzerland for UroShield®
18/12/2018
ELMSFORD, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
Golden Leaf Holdings Ltd. Not Pursuing Terra Tech Corp. Transaction
18/12/2018
TORONTO, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd . (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf”), a cannabis company with cultivation, production and retail operations built around recognized brands [...]
Easton Pharmaceuticals Completes Purchase of Development Project with Total Projected Profit in Excess of $30 Million
18/12/2018
TORONTO, ON, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has closed on an Agreement to acquire a Real Estate Development Project just outside of [...]
Nemaura Publishes Positive Data from SugarBEAT® FDA Clinical Trial
18/12/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018
18/12/2018
CRANBURY, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported financial results and business highlights for its fiscal year ended September 30, 2018. Recent [...]
Imprivata Launches EPCS Ready, a Comprehensive Online Hub for Achieving National and State EPCS Compliance
18/12/2018
National bill requires e-prescribing for controlled substances under Medicare Part D by 2021 LEXINGTON, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Imprivata ® , the healthcare IT security company, today launched EPCS [...]
PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
18/12/2018
Oslo (Norway), 18 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed top-10 pharma [...]
BELLUS Health Closes $35M Financing to Support Development of its Lead Drug Candidate BLU-5937 for Chronic Cough
18/12/2018
Financing led by OrbiMed with Appointment of Mr. Chau Q. Khuong to BELLUS Board of Directors LAVAL, Quebec, Dec. 18, 2018 (GLOBE NEWSWIRE) -- BELLUS Health Inc. (TSX: BLU) (“BELLUS Health” or the “Company”), a clinical- [...]
BELLUS Santé complète un financement de 35 millions $ pour soutenir le développement de son médicament candidat phare, le BLU-5937 pour le traitement de la toux chronique
18/12/2018
OrbiMed a été le principal souscripteur du financement et M. Chau Q. Khuong a été nommé au conseil d'administration de BELLUS LAVAL, Québec, 18 déc. 2018 (GLOBE NEWSWIRE) -- BELLUS Santé inc. (TSX : BLU) (« BELLUS Santé [...]
Medigus in Advanced Negotiations to License its MUSE™ Technology
18/12/2018
OMER, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today [...]
Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering
18/12/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
Agritek Holdings, Inc. Announces Filing Of Quarterly Report Ending September 30th 2018, Return To Fully Reporting Status, And Favorable Settlement Of Arbitration
18/12/2018
LOS ANGELES, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Albireo Granted Orphan Designation by European Commission For Lead Product Candidate A4250 for Treatment of Biliary Atresia
18/12/2018
Expands lead product candidate’s development potential in rare cholestatic liver diseases Provides 10 years market exclusivity upon approval plus 2 years upon completion of PIP BOSTON, Dec. 18, 2018 (GLOBE NEWSWIRE) -- [...]
Intra-Cellular Therapies Announces Update on ITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer's Disease
18/12/2018
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Anchiano Therapeutics Announces Initiation of Its Pivotal Codex Study of Inodiftagene Vixteplasmid in Patients with Non-Muscle-Invasive Bladder Cancer
18/12/2018
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics ( TASE: ANCN ), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today [...]

Pages